KCO-616. Potassium channel opener treatment of urge urinary incontinence

Drugs of the Future

Volumn 25, Issue 3, 2000, Pages 239-245

  Butera, John A ^a   Argentieri, Thomas M ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,4 DICHLORO 6 METHYL BENZYLAMINO) 4 (1,1 DIMETHYLPROPYLAMINO)CYCLOBUT 3 ENE 1,2 DIONE; 3 (2,4 DICHLORO 6 METHYLBENZYLAMINO) 4 (1,1 DIMETHYLPROPYLAMINO) 3 CYCLOBUTENE 1,2 DIONE; 4 [3,4 DIOXO 2 (1,2,2 TRIMETHYLPROPYLAMINO) 1 CYCLOBUTENYLAMINO] 3 ETHYLBENZONITRILE; CROMAKALIM; N (4 BENZOYLPHENYL) 3,3,3 TRIFLUORO 2 HYDROXY 2 METHYLPROPIONAMIDE; OXYBUTYNIN; PINACIDIL; POTASSIUM CHANNEL STIMULATING AGENT; SPASMOLYTIC AGENT; TOLTERODINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; BLADDER INSTABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TOLERABILITY; FEMALE; HYPERPOLARIZATION; NONHUMAN; RAT; URINE INCONTINENCE;

EID: 0034050702     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2000.025.03.568834     Document Type: Article

References (23)

1. Butera, J.A., Antane, M.M., Antane, S.A. et al. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. I. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity. J Med Chem 2000, 43: 1187-202.
2. Butera, J.A., Antane, S.A., Lennox, J.R. et al. Substituted N-aryl-1,2-diaminocyclobutene-3,4-diones. I. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity. 214th ACS Natl Meet (Sept 7-11, Las Vegas) 1997, Abst MEDI 044.
3. Gilbert, A.M., Antane, M.M., Argentieri, T.M. et al. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. II. Selective and potent benzylamino cyclobutenediones. J Med Chem 2000, 43: 1203-14.
4. McFarlane, G.R., Gundersen, E.G., Elokdah, H. et al. Benzylamino analogs of 1,2-diaminocyclobutene-3,4-dione as novel KATP channel openers targeted for the treatment of urge urinary incontinence. 218th ACS Natl Meet (Aug 22-26, New Orleans) 1999, Abst MEDI 35.
5. Resnick, N.M. Urinary incontinence. Lancet 1995, 346: 94-9.
6. American Health Care Policy Research Guideline. Urinary incontinence in adults: Acute and chronic management - clinical practice guideline. Publication No. 96-0682 Rockville MD.
7. Knapp, P.M. Identifying and treating urinary incontinence. Postgrad Med 1998, 103: 279-94.
8. Wein, A.J. Pharmacology of incontinence. Urol Clin North Am 1995, 22: 557-77.
9. Turner, W.H., Brading, A.F. Smooth muscle of the bladder in the normal and the diseased state: Pathophysiology, diagnosis and treatment. Pharmacol Ther 1997, 75: 77-110.
10. Hieble, J.P., Mccafferty, G.P., Naselsky, D.P., Bergsma, D.J., Ruffolo, R.R. Recent progress in the pharmacotherapy of diseases of the lower urinary tract. Eur J Med Chem 1995, 30(Suppl.):269-98s.
11. Hattori, T. Drug treatment of urinary incontinence. Drugs Today 1998, 34: 125-38.
12. Chutka, D.S., Takahashi, P.Y. Urinary incontinence in the elderly, drug treatment options. Drugs 1998, 56: 587-95.
13. Butera, J.A., Argentieri, T.M. Recent approaches to the treatment of urinary incontinence: A survey of patent activity from 1995 to 1998. Exp Opin Ther Patents 1998, 8: 1017-35.
14. Bonev, A.D., Nelson, M.T. ATP-sensitive potassium channels in smooth muscle cells from guinea pig urinary bladder. Am J Physiol 1993, 264: C1190-200.
15. Fujii, K., Foster, C.D., Brading, A.F., Parekh, A.B. Potassium channel blockers and the effects of cromakalim on the smooth muscle of the guinea-pig bladder. Br J Pharmacol 1990, 99: 779-85.
16. Malmgren, A., Andersson, K.E., Andersson, P.O., Fovaeus, M., Sjogren, C. Effects of cromakalim (BRL 34915) and pinacidil on normal and hypertrophied rat detrusor in vitro. J Urol 1990, 143: 828-34.
17. + channel blockers and cromakalim (BRL 34915) on the mechanical activity of guinea-pig detrusor smooth muscle. J Pharmacol Exp Ther 1991, 269: 1158-64.
18. Nurse, D.E., Restorick, J.M., Mundy, A.R. The effect of cromakalim on the normal and hyper-reflexic human detrusor muscle. Br J Urol 1991, 68: 27-31.
19. Restorick, J.M., Nurse, D.E. The effect of cromakalim on human detrusor: An in vitro and in vivo study. Neurourol Urodyn 1988, 7: 207.
20. 86Rb efflux and 3H-P1075 binding in bladder smooth muscle. Pharmacology 1995, 50: 388-97.
21. Howe, B.B., Halterman, T.J., Yochim, C.L. et al. Zeneca ZD6169: A novel KATP channel opener with in vivo selectivity for urinary bladder. J Pharmacol Exp Ther 1995, 274: 884-90.
22. Wojdan, A., Freeden, C., Woods, M. et al. Comparison of the potassium channel openers, WAY-133537, ZD6169 and celikalim on isolated bladder tissue and in vivo bladder instability in the rat. J Pharmacol Exp Ther 1999, 289: 1410-8.
23. Malmgren, A., Sjogren, C., Uvelius, B., et al. Cystometrical evaluation of bladder instability in rats with infravesical outflow obstruction. J Urol 1987, 137: 1291-4.